Brief: Oncotelic Closes Covid-19 Clinical Trial Early
15/06/2021 14:32
June 15 (Reuters) - Oncotelic Therapeutics Inc OTLC.PK :
* ONCOTELIC CLOSES COVID-19 CLINICAL TRIAL EARLY.
Source text for Eikon: ID:nGNX2QCtLM
Further company coverage: OTLC.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oncotelic Therapeutics
See all newsBrief: Oncotelic Therapeutics Emerging As Leader With New Independent JV Valuation
Brief: Oncotelic Therapeutics - JV Is Preparing For A Potential Initial Public Offering On The Hong Kong Stock Exchange In Late 2026
Brief: Oncotelic Therapeutics To Sell Its Necroptosis Cancer Therapy Assets To Mosaic Immunoengineering
Brief: Oncotelic Announces Initiation Of Clinical Study In Non-Small Lung Cell Cancer
Brief: Oncotelic Initiates Clinical Trials Evaluating Ot-101 Against Pediatric Gliomas